Science, innovation and commitment

Researchers discover a key factor that predicts COVID-19 disease severity

A study led by Drs. Laia Alsina and Iolanda Jordan from the IRSJD evidences a key factor that predicts the severity of COVID-19: an alteration of the first immune response to SARS-CoV-2 infection, in key molecules in the anti-infective response. The study has been published in open access in the journal iScience.

New tool to predict severity in Nonketotic Hyperglycinemia, a rare disease

An international team led by Dr Àngels García Cazorla, a researcher at the Institut de Recerca Sant Joan de Déu and a pediatric neurologist at the SJD Barcelona Children’s Hospital, has presented a new approach to nonketotic hyperglycinemia that can predict the severity in affected children. The study was published in the journal Annals of Neurology.

Findings on how gen ‘YWHAZ’ can alter neuronal development

Dr. Bru Cormand and Noèlia Fernàndez (IRSJD) led a research study where reveals the molecular mechanisms to explain how the YWHAZ gene -related to psychiatric and neurological disorders such as autism and schizophrenia- can alter the neurodevelopmental process.

The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first time

Drs. Susana Rives, Montserrat Torrebadell and Nerea Vega (IRSJD) participate in a study led by Dr. Pablo Menéndez, group leader at the Josep Carreras Leukaemia Research Institut, who has identified a previously noticed population of pre-leukemic cells might be responsible for some relapses in B-cell acute lymphoblastic leukemia (B-ALL).

Agenda

#SeminarIRSJD · Reptes i oportunitats de la robòtica en cirurgia

Speaker: Dra. Alicia Casals

Online

15:30h

Interviews

Judith Armstrong

Group leader · Genomics for the diagnosis of rare diseases

"All the researchers on the team know that families and patients are a key part of our research, and we need to be able to pass on what we do."

Read more More Interviews